Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1379432 | 0.82 | TSHR (0.60) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL29137850 | 0.77 | CD44 (0.50) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL1312250 | 0.76 | CYP3A4 (0.43) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL7346771 | 0.76 | CD44 (0.42) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL49876 | 0.75 | — | — | |
| SCHEMBL1698298 | 0.74 | TSHR (0.39) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL16776729 | 0.74 | CD44 (0.72) | CD44TSHRCYP3A4TDP1CYP1A2 | |
| SCHEMBL106244 | 0.74 | — | — | |
| SCHEMBL11416944 | 0.74 | MYC (0.48) | TSHRCYP3A4TDP1ALDH1A1MAPK1 | |
| Acetonitrile SCHEMBL21001777 | 0.73 | CD44 (0.56) | CD44TSHRCYP3A4TDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3523314-A1 | CYCLIC DINUCLEOTIDES CONTAINING BENZIMIDAZOLE, METHOD FOR THE PRODUCTION OF SAME, AND USE OF SAME TO ACTIVATE STIMULATOR OF INTERFERON GENES (STING)-DEPENDENT SIGNALING PATHWAYS | Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb GmbH (DE) | 2019-08-14 | — | — | EP | claimed |
| CN-106932367-B | It is a kind of to detect the method to interact between Rab albumen and its effector based on fluorescence resonance energy transfer method | 青岛农业大学 | 2019-07-19 | — | — | CN | claimed |
| EP-3481842-A1 | NEW EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | Mireca Medicines GmbH (DE) | 2019-05-15 | — | — | EP | claimed |
| WO-2018041942-A9 | NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | MIRECA MEDICINES GMBH (DE) | 2019-01-17 | — | — | WO | claimed |
| WO-2018065360-A1 | CYCLIC DINUCLEOTIDES CONTAINING BENZIMIDAZOLE, METHOD FOR THE PRODUCTION OF SAME, AND USE OF SAME TO ACTIVATE STIMULATOR OF INTERFERON GENES (STING)-DEPENDENT SIGNALING PATHWAYS | BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA-VERTRIEB GMBH (DE) | 2018-04-12 | — | — | WO | claimed |
| WO-2018010965-A1 | NEW EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA-VERTRIEB GMBH (DE) | 2018-01-18 | — | — | WO | claimed |
| EP-2691403-A1 | NEW BORANOPHOSPHATE ANALOGUES OF CYCLIC NUCLEOTIDES | BIOLOG Life Science Institute Forschungslabor Und Biochemica-Vertrieb GmbH (DE) | 2014-02-05 | — | — | EP | claimed |
| WO-2012130829-A1 | NEW BORANOPHOSPHATE ANALOGUES OF CYCLIC NUCLEOTIDES | BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA-VERTRIEB GMBH (DE) | 2012-10-04 | — | — | WO | claimed |
| EP-1494700-A2 | CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS | Cytovia, Inc. (US) | 2005-01-12 | — | — | EP | claimed |
| WO-2004002401-A2 | CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS | CYTOVIA, INC. (US) | 2004-01-08 | — | — | WO | claimed |
| WO-2024112654-A1 | SPIROCYCLIC DIHYDROPYRANOPYRIMIDINE KRAS INHIBITORS | Treeline Biosciences, Inc. (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024040131-A1 | PYRIDOPYRIMIDINE KRAS INHIBITORS | Treeline Biosciences, Inc. (US) | 2024-02-22 | — | — | WO | disclosed |
| EP-4213999-A1 | COMPOUNDS FOR USE IN SYSTEM SUITABILITY TESTING OF INERT LC SYSTEMS AND COLUMNS | Waters Technologies Corporation (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023288316-A1 | METHOD OF USE FOR APOE PEPTIDES | ANJI PHARMA (US) LLC (US) | 2023-01-19 | — | — | WO | disclosed |
| US-10745674-B2 | Polyketide synthase variants and uses thereof | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2020-08-18 | — | — | US | disclosed |
| WO-2004034977-A2 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-04-29 | — | — | WO | disclosed |
| EP-1047496-A1 | THE PREPARATION OF NOVEL GELS FOR THE PURIFICATION OF NON-POLAR EXTRACTIVES | Her Majesty in Right of Canada, represented by The Minister of Agriculture and Agri-Food Canada (CA) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999034916-A1 | THE PREPARATION OF NOVEL GELS FOR THE PURIFICATION OF NON-POLAR EXTRACTIVES | HER MAJESTY IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF AGRICULTURE AND AGRI-FOOD CANADA (CA) | 1999-07-15 | — | — | WO | disclosed |
| US-5798210-A | FLUOROPHORE-SUBSTITUTED CAPROIC ACID ESTER OF DEOXYRIBONUCLEOSIDE CLEAVABLE IN BASIC MEDIUM OR BY ACTION OF ENZYME | INSTITUT PASTEUR (FR) | 1998-08-25 | — | — | US | disclosed |
| US-5039797-A | For reducing intraocular pressure in mammals | YALE UNIVERSITY (US) | 1991-08-13 | — | — | US | disclosed |